TNON
Tenon Medical, Inc.Company Information
- Company Name
- Tenon Medical, Inc.
- CIK
- CIK0001560293
- Category
- <br>Emerging growth company
- Ticker: Exchange
- TNON: Nasdaq, TNONW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- TNON
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-10
- Last sale
- 2026-09-10
- Shares purchased (TTM)
- 229,807
- Shares sold (TTM)
- 69,233
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 884,093
- Shares outstanding
- 328
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -37.58%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Series B Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 5 | 4 | 3 | 8 | 10 | 7 | 9 | 2 | 4 | 2 | 3 | ||||||
| Accounts Receivable Net Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Inventory Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | - | 0 | - | ||||||
| Assets Current | 5 | 8 | 7 | 7 | 10 | 12 | 8 | 11 | 4 | 6 | 4 | 5 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Deferred Costs | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 1 | - | - | - | - | - | - | - | - | ||||||
| Goodwill | 2 | 2 | 2 | 2 | - | - | - | - | - | - | - | - | ||||||
| Assets | 10 | 13 | 11 | 10 | 11 | 13 | 10 | 13 | 6 | 8 | 6 | 7 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Sales Commission Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | - | - | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 4 | 3 | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Derivative Liabilities Current | 0 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 8 | 7 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 12 | 11 | 6 | 6 | 4 | 4 | 4 | 5 | 5 | 4 | 6 | 5 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 84 | 84 | 83 | 80 | 78 | 78 | 71 | 70 | 60 | 59 | 56 | 55 | ||||||
| Retained Earnings Accumulated Deficit | -89 | -85 | -81 | -78 | -75 | -72 | -69 | -66 | -62 | -59 | -55 | -52 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | - | - | - | -0 | -0 | ||||||
| Stockholders Equity | -2 | 2 | 5 | 5 | 7 | 9 | 6 | 8 | 1 | 4 | 1 | 3 | ||||||
| Liabilities And Stockholders Equity | 10 | 13 | 11 | 10 | 11 | 13 | 10 | 13 | 6 | 8 | 6 | 7 | ||||||
| Debt Instrument Unamortized Discount Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | ||||||
| Shares Outstanding | 0 | 11 | 11 | 9 | 8 | 8 | 3 | 3 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Issued | 0 | 11 | 11 | 9 | 8 | 8 | 3 | 3 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTenon Medical, Inc. (TNON) — SEC Financial Statements & Analysis
Tenon Medical, Inc. (TNON) is a surgical & medical instruments & apparatus company, incorporated in DE. Tenon Medical, Inc. trades on Nasdaq as: TNON, TNONW. Tenon Medical, Inc. (TNON)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Tenon Medical, Inc. carries a market cap of $3.74K, a P/E ratio of -0.00x, a P/B ratio of -0.00x, a P/S ratio of 0.00x, an enterprise value of $2.66M, and an EV/EBITDA multiple of -0.21x. On profitability, it posts a gross margin of 66.81%, an operating margin of -242.70%, a net margin of -257.85%, a Return on Equity (ROE) of -551.19%, a Return on Assets (ROA) of -130.22%, and a Return on Invested Capital (ROIC) of -2959.67%. Per share, it reports EPS of $-41759.15, diluted EPS of $-41759.15, free cash flow per share of $-37490.85, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 80.25% year-over-year, net income growth of 8.23% year-over-year, and EPS growth of -28.40% year-over-year. On the balance sheet, it maintains a current ratio of 0.58x, a quick ratio of 0.44x, working capital of $-3.50M, a debt-to-equity ratio of -6.69x, a debt ratio of 1.18, an interest coverage ratio of -12.54x, free cash flow of $-12.30M (TTM), and net debt of $2.65M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.74K
- P/E TTM
- -0.00x
- EPS TTM
- $-41759.15
- P/B TTM
- -0.00x
- ROE TTM
- -551.19%
- ROA TTM
- -130.22%
- Debt To Equity
- -6.69x
- Free Cash Flow TTM
- $-12.30M
- Net Revenue TTM Growth 1Y
- 80.25%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Tenon Medical, Inc. in?
Tenon Medical, Inc. (TNON) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does TNON trade on?
Tenon Medical, Inc. (TNON) trades on the Nasdaq.
Where is Tenon Medical, Inc. incorporated?
Tenon Medical, Inc. is incorporated in DE.
When was Tenon Medical, Inc. (TNON)'s most recent SEC filing?
Tenon Medical, Inc. (TNON)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is TNON's market cap?
Tenon Medical, Inc. (TNON) has a market capitalization of $3.74K as of 2026-06-30.
What is TNON's EPS (earnings per share)?
Tenon Medical, Inc. (TNON)'s trailing twelve month EPS is $-41759.15 as of 2026-06-30.
What is TNON's ROE (return on equity)?
Tenon Medical, Inc. (TNON)'s trailing twelve month Return on Equity (ROE) is -551.19% as of 2026-06-30.
What is TNON's ROA (return on assets)?
Tenon Medical, Inc. (TNON)'s trailing twelve month Return on Assets (ROA) is -130.22% as of 2026-06-30.
What is TNON's ROIC (return on invested capital)?
Tenon Medical, Inc. (TNON)'s trailing twelve month Return on Invested Capital (ROIC) is -2959.67% as of 2025-12-31.
What is TNON's EV/EBITDA?
Tenon Medical, Inc. (TNON)'s trailing twelve month EV/EBITDA is -0.21x as of 2026-06-30.